Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2024-06-07 | 2025-04-28 | 229945 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136314 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138294 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155152 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86846 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-06-27 | 2019-11-01 | 87690 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-08-22 | 2019-11-01 | 92192 |
| TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211985 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2024-01-25 | 2024-02-08 | 217237 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2024-02-22 | 2024-12-19 | 220267 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2024-03-28 | 2024-09-19 | 223853 |
| TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2024-07-04 | 2025-01-16 | 232232 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2024-07-18 | 2024-09-19 | 233273 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195557 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-01-09 | 2020-06-25 | 102890 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-01-09 | 2020-06-11 | 102898 |
| TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2020-01-09 | 2020-08-21 | 102931 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-02-07 | 2020-06-11 | 105583 |
| TEVA-CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-10-17 | 2025-05-02 | 240519 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| TEVA-DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
| TEVA-DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
| TEVA-DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
| TEVA-DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
| TEVA-DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 |